Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 4:12:23743735251323387.
doi: 10.1177/23743735251323387. eCollection 2025.

Exploring Patients' Motivations in Using Platelet-Rich Plasma as Their Primary Care Therapy for Managing Knee Osteoarthritis: A Focus Group Discussion

Affiliations

Exploring Patients' Motivations in Using Platelet-Rich Plasma as Their Primary Care Therapy for Managing Knee Osteoarthritis: A Focus Group Discussion

Maria Ruth Pineda-Cortel et al. J Patient Exp. .

Abstract

Knee osteoarthritis (KOA) is a degenerative disease that causes pain and burden in patients. Aside from surgery, clinicians tout the potential use of platelet-rich plasma. This study explores motivation in terms of perceptions, experiences, and recommendations of KOA patients who received platelet-rich plasma (PRP) as primary care therapy. A qualitative approach via focus group discussion was conducted. Data were analyzed using thematic analysis and visualized using MAXQDA. Patients' motivation for the use of PRP was based on three factors: (1) their perception of PRP as a therapy, (2) their lived experiences post-PRP therapy, and (3) their willingness to recommend PRP to others as a primary care therapy. The elements of each theme were identified and ranked based on how often the patients expressed the same thought, with willingness (f=5), alternative therapy (f=7), and pain (f=27) ranking highest. Physicians' recommendations, preference for a non-surgical approach, and later on, reduced pain and improved quality of life made them believe in the effectiveness of PRP as primary care therapy to alleviate KOA symptoms.

Keywords: biologic therapy; chronic pain management; knee osteoarthritis; platelet-rich plasma; primary care.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Codification of PRP treatment to KOA based on user's perceptions, experiences, and recommendations (MAXMap).

Similar articles

References

    1. Sen R, Hurley JA. Osteoarthritis [Internet]. Nih.gov. StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482326/
    1. Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinMed. 2020;29-30:100587. doi:10.1016/j.eclinm.2020.100587 - DOI - PMC - PubMed
    1. Racaza GZ, Salido EO, Penserga EG. Clinical profile of Filipino patients with osteoarthritis seen at two arthritis clinics (for the osteoarthritis network of the Philippine general hospital). Osteoarthritis and Cartilage. 2012;20:S193. - PubMed
    1. Grässel S, Muschter D. Recent advances in the treatment of osteoarthritis. F1000Res. 2020;9(1):1-17. - PMC - PubMed
    1. Ghouri A, Quicke JG, Conaghan PG. New developments in osteoarthritis pharmacological therapies. Rheumatology. 2021;60(Supplement_6):vi1-11. - PMC - PubMed

LinkOut - more resources